MKLNF (M1 Kliniken AG) Growth Rank: 7 (As of Sep. 08, 2026) — Near Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MKLNF M1 Kliniken AG MKLNF
89 GF Score
Price $11.73
GF Value $9.57
! 3 Warning Signs
View Full Analysis

What is M1 Kliniken AG Growth Rank?

M1 Kliniken AG MKLNF 89 Growth Rank is 7 as of Sep. 08, 2026, which is at its 10-year median of 7.00. GuruFocus rates MKLNF with a GF Score™ of 89/100 and a GF Value™ of $9.57. The stock has 3 warning signs investors should review.

M1 Kliniken AG has the Growth Rank of 7.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability, rated on a scale from 1 to 10. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

A higher score reflects a greater ability to drive business growth, with companies considered to have strong and sustainable expansion potential. Conversely, a lower score indicates challenges in achieving consistent growth and scalability.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.

M1 Kliniken AG Growth Rank Related Terms

MKLNF vs MCK, COR, CAH: Growth Rank Comparison

For the Medical Distribution subindustry, M1 Kliniken AG's Growth Rank, along with its competitors' market caps and Growth Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

M1 Kliniken AG Growth Rank vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, M1 Kliniken AG's Growth Rank distribution charts can be found below:

* The bar in red indicates where M1 Kliniken AG's Growth Rank falls into.


MKLNF
89GF Score
M1 Kliniken AG MKLNF
Growth Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Growth Rank →
What does a Growth Rank of 7 mean?
M1 Kliniken AG (MKLNF) has a Growth Rank of 7 as of Sep. 08, 2026. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on M1 Kliniken AG and its competitors. This is near median its historical median of 7.00. Over the past decade, M1 Kliniken AG's Growth Rank has ranged from 4.00 to 10.00.
Is M1 Kliniken AG's Growth Rank too high?
M1 Kliniken AG's current Growth Rank of 7 is near median its 10-year median of 7.00. Over the past 10 years, this metric has ranged from a low of 4.00 to a high of 10.00. Overall, M1 Kliniken AG has a GF Score™ of 89/100, reflecting its overall financial health beyond just this single metric.
How does M1 Kliniken AG's Growth Rank compare to MCK and COR?
M1 Kliniken AG's Growth Rank of 7 can be compared against companies in the Medical Distribution industry. Historically, M1 Kliniken AG's own Growth Rank has ranged from 4.00 to 10.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Growth Rank for a Medical Distribution company?
A good Growth Rank depends on the Medical Distribution industry context. However, Growth Rank should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Growth Rank mean?
A high Growth Rank can signal that a stock is expensive relative to its fundamentals. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on M1 Kliniken AG and its competitors. M1 Kliniken AG's current Growth Rank is 7, which is near median its own 10-year median of 7.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is M1 Kliniken AG stock overvalued right now?
M1 Kliniken AG (MKLNF) has a current Growth Rank of 7. The stock's GF Value™ is $9.57, compared to a current price of $11.73 — trading 22.6% above its estimated fair value. The current Growth Rank is 7, which is near median its 10-year median of 7.00. M1 Kliniken AG's overall GF Score™ is 89/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Growth Rank calculated?
Growth Rank is calculated from a company's financial statements. For M1 Kliniken AG (MKLNF), the current Growth Rank is 7 as of Sep. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is M1 Kliniken AG (MKLNF) Overvalued in 2026?

Based on GuruFocus' analysis, M1 Kliniken AG stock appears to be overvalued. The current stock price of $11.73 is trading 22.6% above its estimated GF Value™ of $9.57.

Key valuation signals for MKLNF:

  • Growth Rank: 7 (near median its 10-year median of 7.00)
  • GF Value™: $9.57 vs. price of $11.73 (22.6% above fair value)
  • GF Score™: 89/100 with 3 warning signs

No single metric tells the full story. See the MKLNF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

M1 Kliniken AG Business Description

Other Exchanges M12:Germany
Address Grunauer strasse 5, Berlin, BB, DEU, 12557
M1 Kliniken AG operates in the growing market of aesthetic medicine and plastic surgery and provides aesthetic medical treatments in the self-pay segment. It operates through Beauty and Trade segments. Its activities are focused on providing aesthetic medical treatment. In addition to medical aesthetic treatments, the company also develops and markets pharmaceutical, medical, and medical technology products for aesthetic surgery and cosmetic dermatology. Some of the treatments offered by the group are lip under injection, eyebrow lift, tummy tuck, breast reduction, sweat treatment, liposuction, and others. The organization conducts its business operations in Germany. The majority of its revenue is derived from the Trade segment.
89GF Score

Get the complete analysis for MKLNF

Growth Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$11.73
Price
$9.57
GF Value